Bhatia A, Mehra R, Bauman J, Khan SA, et al. Phase II Trial of Chemotherapy, Cetuximab, and Erlotinib in Patients With Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck. Head Neck 2025 Apr 1. doi: 10.1002/hed.28152.
PMID: 40166973